Amazon exec Lathia joins Flagship-backed Valo as chief product officer; plus AavantiBio, CatalYm, Corcept, Vincerx, OnCusp and more

Flagship-backed cloud computing-based drug discovery and development company Valo Health LLC named Nish Lathia chief product officer. The 18-year veteran of Amazon.com Inc. (NASDAQ:AMZN) held a variety of ecommerce and web services roles at that company; he was most recently general manager for worldwide heavy bulky products and services. 

Less than five months after closing a $107 million series A round, gene therapy company AavantiBio Inc. has named Douglas Swirsky CFO. He most recently was CEO of Rexahn Pharmaceuticals Inc. through its 2020 merger with Ocuphire Pharma Inc. (NASDAQ:OCUP)...